Rockefeller Capital Management’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.1M | Buy |
562,921
+39,753
| +8% | +$1.85M | 0.05% | 364 |
|
|
2025
Q4 | $25.4M | Buy |
523,168
+126,381
| +32% | +$6.26M | 0.05% | 380 |
|
|
2025
Q3 | $18.7M | Buy |
396,787
+26,606
| +7% | +$1.28M | 0.04% | 432 |
|
|
2025
Q2 | $17.9M | Sell |
370,181
-20,928
| -5% | -$1.07M | 0.04% | 421 |
|
|
2025
Q1 | $21.7M | Buy |
391,109
+37,864
| +11% | +$2.05M | 0.05% | 338 |
|
|
2024
Q4 | $17M | Sell |
353,245
-7,037
| -2% | -$358K | 0.04% | 386 |
|
|
2024
Q3 | $20.8M | Buy |
360,282
+72,065
| +25% | +$3.89M | 0.06% | 325 |
|
|
2024
Q2 | $14M | Sell |
288,217
-51,283
| -15% | -$2.47M | 0.04% | 413 |
|
|
2024
Q1 | $16.5M | Buy |
339,500
+122,390
| +56% | +$5.98M | 0.05% | 375 |
|
|
2023
Q4 | $10.8M | Sell |
217,110
-15,736
| -7% | -$769K | 0.04% | 430 |
|
|
2023
Q3 | $12.5M | Buy |
232,846
+31,886
| +16% | +$1.7M | 0.05% | 363 |
|
|
2023
Q2 | $10.8M | Buy |
200,960
+22,717
| +13% | +$1.22M | 0.04% | 408 |
|
|
2023
Q1 | $9.7M | Buy |
178,243
+3,723
| +2% | +$181K | 0.04% | 412 |
|
|
2022
Q4 | $8.45M | Sell |
174,520
-19,420
| -10% | -$852K | 0.04% | 400 |
|
|
2022
Q3 | $7.37M | Buy |
193,940
+8,946
| +5% | +$399K | 0.04% | 445 |
|
|
2022
Q2 | $9.25M | Buy |
184,994
+14,735
| +9% | +$782K | 0.05% | 365 |
|
|
2022
Q1 | $8.74M | Buy |
170,259
+16,746
| +11% | +$865K | 0.04% | 397 |
|
|
2021
Q4 | $7.69M | Sell |
153,513
-7,367
| -5% | -$364K | 0.04% | 408 |
|
|
2021
Q3 | $7.75M | Buy |
160,880
+9,915
| +7% | +$504K | 0.04% | 364 |
|
|
2021
Q2 | $7.95M | Buy |
150,965
+19,350
| +15% | +$1.01M | 0.04% | 341 |
|
|
2021
Q1 | $6.51M | Buy |
131,615
+15,455
| +13% | +$742K | 0.04% | 315 |
|
|
2020
Q4 | $5.64M | Buy |
116,160
+53,807
| +86% | +$2.65M | 0.04% | 305 |
|
|
2020
Q3 | $3.13M | Buy |
62,353
+41,182
| +195% | +$2.12M | 0.03% | 341 |
|
|
2020
Q2 | $1.08M | Buy |
21,171
+6,119
| +41% | +$297K | 0.01% | 532 |
|
|
2020
Q1 | $658K | Buy |
15,052
+1,892
| +14% | +$90.5K | 0.01% | 555 |
|
|
2019
Q4 | $661K | Buy |
13,160
+11,540
| +712% | +$541K | 0.01% | 524 |
|
|
2019
Q3 | $75K | Sell |
1,620
-9,301
| -85% | -$401K | ﹤0.01% | 862 |
|
|
2019
Q2 | $473K | Sell |
10,921
-26,614
| -71% | -$1.13M | 0.01% | 465 |
|
|
2019
Q1 | $1.66M | Buy |
37,535
+37,360
| +21,349% | +$1.6M | 0.02% | 292 |
|
|
2018
Q4 | $8K | Buy |
+175
| New | +$7.72K | ﹤0.01% | 744 |
|
|
2018
Q2 | – | Sell |
-8,716
| Closed | -$349K | – | 783 |
|
|
2018
Q1 | $349K | Buy |
+8,716
| New | +$363K | 0.01% | 296 |
|
Other funds holding SNY
MIP
Rockefeller Capital Management's SNY Position: Q1 2026 in Review
Rockefeller Capital Management increased its Sanofi (SNY) stake by 7.6% in Q1 2026, buying an estimated $1.85M and bringing the position to 562,921 shares worth $27.1M. The position accounts for 0.05% of the portfolio, ranked #364.
Rockefeller Capital Management first reported a position in SNY in Q1 2018 and has held it in 31 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Rockefeller Capital Management held 562,921 shares of Sanofi worth $27.1M as of Q1 2026.
- Rockefeller Capital Management bought 39,753 Sanofi shares in Q1 2026, an estimated $1.85M.
- Sanofi made up 0.05% of Rockefeller Capital Management's portfolio in Q1 2026, its #364 holding.
- Rockefeller Capital Management first reported a position in Sanofi in Q1 2018 and has held it in 31 quarters since.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.